安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Guidance for Clinical Investigators, Industry, and FDA Staff
update this information if any relevant changes occur during the study and for one year following its completion A Definitions
- 21 CFR Part 54 -- Financial Disclosure by Clinical Investigators
This section and conforming regulations require an applicant whose submission relies in part on clinical data to disclose certain financial arrangements between sponsor(s) of the covered studies and the clinical investigators and certain interests of the clinical investigators in the product under study or in the sponsor of the covered studies
- FDA’s Requirements for Financial Disclosure
A detailed description of FDA requirements for financial disclosure by clinical investigators The content includes; 1) Five key definitions, 2) Five significant penalties for noncompliance, 3) Dollar thresholds that trigger reporting requirements
- Protocol Registration Financial Disclosure Frequently Asked Questions
All original, completed and signed FD forms statements must be filed and retained in a CRS’s regulatory binder along with the original and or updated, signed Form FDA 1572 for that study These forms should not be submitted to DAIDS or the Network Operations Centers unless requested
- A GUIDE TO FINANCIAL DISCLOSURES - medschool. duke. edu
What Do I Do If My Study Requires Financial Disclosures? A Financial Disclosure template is available on the ORAQ website for clinical investigators to complete The completed Financial Disclosure forms are never submitted to Investigational New Drug (IND) or Investigational Device Exemption (IDE) applications
- SEC Updates Form 20-F and Form 40-F MD A and Other Financial Disclosure . . .
The SEC has adopted amendments to the financial disclosure requirements of Regulation S-K, including the requirements (set out in Item 303) governing the presentation of Management’s Discussion and Analysis (MD A) (available here)
- Financial Disclosures by Clinical Investigators | FDA
In this document, FDA proposed to require disclosure by applicants of the following types of financial interests and arrangements: Compensation made to the clinical investigator in which the
- eCFR :: 5 CFR 2634. 201 -- General requirements, filing dates, and . . .
(1) Within 30 days of assuming a public filer position or office described in § 2634 202, an individual must file a public financial disclosure report containing the information prescribed in subpart C of this part (2) However, no report will be required if the individual:
|
|
|